2024-12-22 23:03:18
New ZIRCON Phase III Data Presented at SNMMI: Potential Utility of TLX250-CDx in Staging and Monitoring ccRCC
Corporate/ 2023-07-24
New ZIRCON Phase III Data Presented at S...

MELBOURNE,Australia,June 27,2023-- Telix Pharmaceuticals Limited (ASX: TLX,Telix,the Company)today announces further details of the positive...

Lion TCR Secures USD 40 million Series B2 Financing, Revolutionizing Solid Tumor Treatment with mRNA-Encoding TCR-T Cell Therapy
Health/ 2023-07-22
Lion TCR Secures USD 40 million Series B...

SINGAPORE and GUANGZHOU,China,June 27,2023-- 27 June 2023,Lion TCR,a clinical-stage T-cell immunotherapy company,is thrilled to announce the...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release